ABSTRACT By using immunoelectron microscopy, we have localized the binding site on 50S Escherichia coli ribosomal subunits for puromycin, an antibiotic that interacts with the ribosomal peptidyltransferase center. This was achieved by affinity-labeling 50S subunits with N-bromoacetyl puromycin and treating the labeled subunits with an antibody specific for the N6,N6-dimethyladenosine moiety of puromycin. The position of the puromycin binding site was then revealed by localizing the attachment sites of the IgG molecules on the surfaces of the 50S subunits under the electron microscope: it was located at the interface between the subunits, on and around the wider lateral protuberance ofthe 50S subunit. This localizes directly the peptidyl transferase center on the surface of the large ribosomal subunit.
Puromycin inhibits protein synthesis by substituting for the incoming coded aminoacyl-tRNA and serving as an acceptor for the nascent peptide chain of ribosome-bound peptidyl-tRNA (1) . This results in premature release of incomplete polypeptides. The mode of action ofpuromycin is well understood. The antibiotic is an analogue of the 3'-terminal end of aminoacyltRNA and therefore interacts with the acceptor site of the peptidyl transferase center on the large ribosomal subunit. Determination of the puromycin binding site on 50S ribosomal sub-. units would thus also determine the location of the ribosomal peptidyl transferase center.
We describe here experiments designed to locate this functional region by immunoelectron microscopy, using an antibody against puromycin. Because ofthe low affinity ofpuromycin for its ribosomal binding site (2) , the antibiotic was bound covalently to 50S subunits, using N-bromoacetyl puromycin (the bromoacetyl group is bound to the nitrogen that mimics the a-NH2 nitrogen ofthe aminoacyl-tRNA) as an affinity label for the peptidyl transferase center.
MATERIALS AND METHODS
Antiserum against N6,N6-dimethyladenosine conjugated to bovine serum albumin (3) was raised in rabbits. The synthesis of N6,N6-dimethyladenosine (4) , the preparation of immunogens, the immunization procedure, the characterization of the antiserum, and the purification of IgG used in this investigation have been described elsewhere (5) . In Ribosomes. 70S ribosomal tight couples from E. coli MRE 600 were isolated as described (6) . 50S and 30S ribosomal subunits were prepared by zonal centrifugation (7) and, after separation, were concentrated by high speed centrifugation (6) .
Affinity Labeling of 50S Subunits. N-Bromo[3H]acetyl puromycin (specific activity, 20 Ci/mol) was synthesized as described (8) . Two nanomoles of heat-reactivated 50S subunits (6) was incubated at 37°C with 100 nmol of N-bromo[3H]acetyl puromycin in 2 ml of buffer I (10 mM. Mg(OAc)2/100 mM NH4C1/20 mM Hepes, pH 7.4). The reaction was terminated after 2 hr by adding 2-mercaptoethanol to a final concentration of 10 mM. Excess puromycin analogue was removed by centrifuging the reaction mixture through 2 ml of 10% sucrose in buffer I in a Beckman 50 Ti rotor for 4 hr at 45,000 rpm. The ribosome pellet was dissolved in 500 ,u1 ofbuffer I, and the subunits were dialyzed against 500 ml of buffer 1/5 mM 2-mercaptoethanol (three times, 3 hr each). The amount of Nbromo[3H]acetyl puromycin that had reacted with 50S ribosomes was determined by measuring the radioactivity; 1100 dpm, 2.8 A2w 50S subunits. The yield of covalently bound puromycin was 25% based on 50S subunits.
Electron Microscopy. Samples for electron microscopy were taken from the sucrose gradients as indicated in Fig. 1 . The samples were placed on grids by using the double-layer carbon technique (9) , and the specimens were negatively contrasted with 0.5% uranyl acetate. Photographs were taken at instrumental magnifications of 71,000 or 110,000 in a Philips EM 301 operated at 80 kV.
RESULTS
Affinity Labeling of 50S Ribosomal Subunits with N-Bromoacetyl Puromycin and Reaction with Antibody. 50S ribosomal subunits were incubated with N-bromo[3H]acetyl puromycin, resulting in 25% labeling.
For localization of the puromycin binding site, we used IgG specific for the dimethyladenosine moiety of the antibiotic. Affinity-labeled 50S subunits were treated with antibody and subjected to sucrose density gradient centrifugation to separate the ribosome-IgG complexes from the unreacted 50S subunits and excess antibody. In the presence of specific antibody, a shoulder was obtained that sedimented faster than the 50S subunits and amounted to 15% of the total 50S subunits at the optimal antibody concentration (Fig. la) . The ribosome-bound puromycin residue was thus available for antibody binding on at least 60% of the affinity-labeled subunits. Such 50S sub-Biochemistry: Luhrmann et at unit-antibody complexes were formed only when affinity-labeled 50S subunits were incubated with antibody against puromycin; they were not formed in control experiments using [3H]puromycin instead of the affinity analogue (Fig. lb) or IgG prepared from a pre-immune serum (Fig. ic) .
Electron Microscopy of Affinity-Labeled 50S SubunitAntibody Complexes. The dimer peak from the sucrose density gradient shown in Fig. la Quasisymmetric crown-shaped 50S subunits were predominant; asymmetric kidney-shaped subunits were rare. The shapes, dimensions, and adsorption behavior of puromycin-labeled 50S subunits were indistinguishable from those of unmodified S0S particles.
Examples ofantibody-dimerized subunits in which both subunits assume the crown-shaped image are shown in Fig. 2 b and c. The subunits in each pair are related by a rotation of9O°-180°a bout a vertical axis. In 95% of the interpretable 5OS-antibody complexes, the Fab arms of the connecting antibody molecules were bound to a region on the 50S particle located around the wider lateral protuberance opposite the rod-like appendage ( Fig. 2 b and c; see Fig. 3a for nomenclature). The same binding site was deduced from monomeric 50S subunits with a single attached antibody molecule (Fig. 2d) . The apparent area ofcontact between the antibody and the crown-shaped 50S subunits is illustrated by drawings (Fig. 2 b6-e6; Fig. 3bl ). Antibody binding to kidney-shaped 50S subunits was observed in -5% of the subunit-antibody complexes evaluated, and here the antibody was bound to the concave side of the subunit; the points of binding of the Fab arms were in a region extending from the base ofthe notch toward the blunted end ( Fig. 2 e andf) . Evaluation of the kidney-shaped 50S subunits having bound IgG molecules made it possible to propose a single site for the antibody binding region (Fig. 3b2) From  Fig. 2 , the puromycin binding site on 50S subunits appears to be in an area between the central protuberance and the wider lateral protuberance but closer to the latter (Fig. 3c) . The rodlike appendage is separated from the puromycin binding site by -'200 A (Fig. 3c) .
The localization of the antibody binding site on the kidneyshaped subunits (Fig. 2 e and f; Fig. 3b2 ) allows the further conclusion that the puromycin binding site is located at the interface between the 50S and the 30S subunits since the concave side of the 50S subunit bearing the notch faces the 30S subunit in each of the proposed 70S models (9) (10) (11) (12) (13) (14) (15) .
Independent of antibody-labeling studies. it has been suggested (9-15) that the wider lateral protuberance in the crownshaped subunits (position 3 in Fig. 3al ) and the bulge between the notch and the blunted end in the kidney-shaped subunits (Fig. 3a2, position 6 ) corresponds to one and the same area in the three-dimensional model of the 50S subunit (see Fig. 3c ).
This assumption is supported by the observation of subunit dimers in which the antibody connects a crown-shaped particle with a kidney-shaped subunit (Fig. 2f) . These subunit-antibody complexes are of particular importance for the three-dimensional localization of the antibody binding site, because they show that two sites, apparently different when seen on twodimensional electron micrographs, correspond to a single site in the three-dimensional structure.
The puromycin binding site and thus the peptidyl transferase center have been located on a distinctive structural feature of the S0S subunit (16, 17) . This area is also well defined on the three-dimensional models ofthe 50S subunit proposed by Lake (11) and by Boublik et at (12) . Because the electron micrographs of negatively contrasted 50S subunits published by these workers are similar to, those described here, we have attempted to project the puromycin binding site onto the three-dimensional 50S subunit models proposed by them.
In the 50S model ofBoublik et at (12) , the puromycin binding site can be located near the smaller "right" crest (Fig. 3d) by assuming that the more elongated side crest corresponds to the stalk described by Lake-(11) and Stoffler et aL (14) (15) (16) .
In the case ofthe model ofthe 50S subunit proposed by Lake (11), the puromycin binding site would be located on or in.the vicinity ofthe one lateral protuberance, which is shorter, blunter, and wider than the rod-like appendage (Fig. 3e) . It is noteworthy that this area is in a region that has been proposed as location of the peptidyl transferase center on the basis of an indirect approach (18) .
DISCUSSION
Our study of the location of the puromycin binding site on 50S ribosomal subunits showed a single antibody binding .site located on one of the most distinctive structural features of the SOS subunits (see Fig. 3 ). The Evidence must be provided that the labeling occurred in a site-specific manner, and the identities of labeled ribosomal components must be convincingly established. Of the several affinity analogues ofpuromycin (see ref. 19) , the N-bromoacetyl derivative fulfils these criteria best for several reasons. (i) Several electrophoretic and immunological methods have been used for the identification of the protein labeled by N-bromoacetyl puromycin; it is principally proteins L1, L2, L23, and L27 that react with the puromycin analogue (unpublished results).
(ii) Previous studies have shown that covalently bound N-iodoacetyl puromycin inhibits the binding of C-A-C-C-A-LeuAc to labeled 50S subunits, suggesting a P-site labeling process (20) . The fact that the puromycin analogue bound at a single distinct topographical site on 50S ribosomal subunits (see Figs. 2 and 3) rather than to various sites scattered over the surface of the 50S subunit further indicated that the labeling was specific. A variety of other data support our notion that we have located the peptidyl transferase center, although the resolution does not suffice to distinguish A and P sites at this point. The puromycin binding site reported here is near the ribosomal binding site for another peptidyl transferase inhibitor, chloramphenicol, which has been determined by electron microscopy of immunoprecipitates with an amphenicol-specific antibody (16, 17) .
The locations ofthe four proteins labeled with N-bromoacetyl puromycin (L1, L2, L23, and L27) have been determined with protein-specific antibodies. Protein L1, protein L2, protein L23, and protein L27 all have antigenic determinants exposed in an area near the puromycin binding site (10, 16, 18, 21, 22) .
Moreover, each ofthese proteins is implicated in other affinitylabeling studies ofpeptidyl transferase (19, 23) and is among the crosslinks between "peptidyl transferase proteins" (24) . Protein L2 is also one of the five proteins essential for peptidyl transferase activity as judged from reconstitution experiments (25) .
Other studies have led to the identification of other proteins, (i.e., Lii, L16, and L18) at or near the peptidyl transferase center (cf. refs. 19, 23, and 25) . Ofthese, L16 and L18 have also been located relatively close to the puromycin site reported here; for Lii, the correspondence is less satisfactory (16) .
The localization ofa reaction site ofpuromycin with 30S subunits, by using immunoelectron microscopy, has recently been reported (26) . This site was mapped on the top of the head of the small subunit. Although the functional significance of this binding site has not been established, it has been pointed out that such a site may be a part of a common puromycin affinity site in 70S ribosomes. This site, is, however, quite remote from the peptidyl transferase center in the 70S models proposed by Lake (18) and by us (14, 15, 27) .
The decoding region on the 30S ribosomal subunit has been found at a distinctive structural feature of the small subunit bv several investigators (for review, see ref. 27 ). The puromycin binding site deduced from two-dimensional electron micrographs of 50S subunits is sufficiently well defined to allow a tentative three-dimensional localization on each ofthe three 50S subunit models so far proposed (Fig. 3 c-e) and also allows deductions as to the location of the peptidyl transferase center on the 50S ribosome. Combining these sets ofdata would, in principle, suffice for the construction ofa model ofthe arrangement of tRNAs in the functioning ribosome. Indeed, proposals as to the arrangement of mRNA and tRNA in the monomeric ribosome have been made (16, 18, 23, 27) . However, these models require that the structures of the ribosomal subunits be elucidated. This question has been approached by three-dimensional image reconstruction of single negatively contrasted ribosomal particles (28) and ofcrystals ofribosomal subunits (29) . kidney-shaped subunits was further substantiated by electron micrographs of ethanol-precipitated 50S subunits treated with the puromycin analogue, which showed kidney-shaped subunits more frequently (16) . Bars = 50 nm. 
